Unusual responses to PCSK9 inhibitors in a clinical cohort utilizing a structured follow-up protocol
Objective: To characterize unusual responses to PCSK9 inhibitor (PCSK9i) therapy in a real-world setting, given their extremely low prevalence in clinical trials. Methods: A retrospective study of patients seen in a structured academic PCSK9i clinic who had LDL-C measurements before and after initia...
Saved in:
| Main Authors: | , , , , , , , |
|---|---|
| Format: | Book |
| Published: |
Elsevier,
2020-03-01T00:00:00Z.
|
| Subjects: | |
| Online Access: | Connect to this object online. |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|